# Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders

> **NCT01817283** · PHASE1,PHASE2 · UNKNOWN · sponsor: **LI Taisheng** · enrollment: 150 (estimated)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Triptolide
- **DRUG:** cART
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01817283
- **Lead sponsor:** LI Taisheng
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2014-07
- **Final completion:** 2015-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2013-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01817283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01817283, "Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT01817283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*